Contact us
Home
Publications
Search
Your Account
Help
Resources
Currently 10778 items...
Last updated 08 Oct 2008
Animal / Veterinary
(23)
Biotechnology
(391)
Chemicals
(45)
Company Financials
(2337)
Company Information
(1596)
Country
(715)
Deals & Alliances
(640)
Dental
(13)
Diagnostics
(116)
Dietary
(87)
Diseases
(417)
Drug Delivery
(78)
Drug Discovery
(89)
Finance / Investment
(18)
General Industry
(120)
Generic Drugs
(348)
Healthcare
(265)
IT & eHealth
(136)
Management / Strategy
(64)
Medical Devices
(1025)
Medical Supplies
(13)
OTC drugs
(210)
Pharmacy
(61)
Prescription Drugs
(39)
Production / Manufacturing
(63)
Regulation & Policy
(98)
Research (R&D)
(1071)
Sales & Marketing
(74)
Technology
(114)
Therapeutic
(128)
Treatments
(509)
Advanced Search
Log In
View Basket
Update Your Details
Order History
How to Buy
Formats & Delivery
Account Options
Terms & Conditions
Free Newsletter & Alerts
Industry Events
News
Special Offers »
Home
|
Search
|
Results
Search Results
Refine your Search
Results for 'Medarex Inc - Deals and Alliances Report'
email this page
print page
Title
Publication Date
Price
Relevance
Medarex Inc. -Deals & Alliances Report
February 2008
£300
100 %
Partneringdesk deals and alliances in autoimmune & inflammatory diseases
April 2006
£1250
40.5 %
Medarex Inc -Detailed Product Pipeline
February 2008
£375
35 %
Drug Delivery Systems
US Market Outlook, Advances for Pharma, Biotech & Medical Devices
September 2006
£1140
35 %
Monoclonal Antibody Therapies
Evolving into a $30 billion market
April 2005
£8000
32.2 %
Monoclonal Antibody Therapies 2004
Entering A New Competitive Era
May 2004
£1115
18.55 %
Schering AG
Prospects to 2010
November 2006
£895
9.1 %
Therapeutic Monoclonal Antibodies Report 2008-2023
July 2008
£0
8.75 %
Bookmark this Category
Del.icio.us
|
StumbleUpon
|
Reddit
Advertiser Links
back
|
top
© 2008 Piribo Limited
About us
|
Jobs at Piribo
|
Affiliates / Advertising
|
Contact us
|
Custom Research
|
Privacy & security
Deutsch
Español
Français
Italiano
عربي (Arabic)
日本語 (Japanese)
简介 (Chinese)